
NeoGenomics NEO
$ 12.4
0.16%
Quarterly report 2025-Q2
added 07-29-2025
NeoGenomics Operating Cycle 2011-2026 | NEO
Annual Operating Cycle NeoGenomics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 | 103 | 110 | 115 | 114 | 109 | 123 | 105 | 100 | 212 | 106 | 127 | 106 | 84.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 212 | 84.5 | 115 |
Quarterly Operating Cycle NeoGenomics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105 | 109 | - | 104 | 101 | 102 | - | 102 | 102 | 106 | - | 105 | 107 | 114 | - | 106 | 107 | 114 | - | 115 | 158 | 120 | 80.5 | 107 | 109 | 103 | 91.8 | 123 | 125 | 119 | 89.8 | 113 | 108 | 110 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 158 | 80.5 | 109 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
275 | $ 3.1 | 2.31 % | $ 101 K | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 39.16 | -0.89 % | $ 1.09 B | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 33.54 | -5.15 % | $ 361 M | ||
|
Danaher Corporation
DHR
|
150 | $ 219.62 | -2.19 % | $ 161 B | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
269 | $ 102.3 | 0.05 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.24 | -0.61 % | $ 793 M | ||
|
BioNano Genomics
BNGO
|
329 | $ 1.47 | -2.65 % | $ 1.87 M | ||
|
Guardant Health
GH
|
49.1 | $ 110.48 | 0.68 % | $ 13.6 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
405 | - | - | $ 79.8 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
116 | $ 66.68 | 0.56 % | $ 4.61 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
204 | $ 74.0 | 0.87 % | $ 28.6 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.8 | 1.66 % | $ 1.12 B | ||
|
DarioHealth Corp.
DRIO
|
251 | $ 10.3 | -6.02 % | $ 292 M | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Precipio
PRPO
|
49.8 | $ 24.26 | -1.98 % | $ 31.5 M | ||
|
Personalis
PSNL
|
55.8 | $ 9.97 | -0.2 % | $ 591 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
198 | $ 149.69 | -0.11 % | $ 23.8 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 235.62 | -1.73 % | $ 42.7 B | ||
|
Thermo Fisher Scientific
TMO
|
69.8 | $ 592.16 | -2.61 % | $ 226 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.87 | -4.13 % | $ 61.9 M | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 211.68 | -2.4 % | $ 10.9 B | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 41.58 | -1.02 % | $ 2.49 B | ||
|
Medpace Holdings
MEDP
|
51.5 | $ 593.07 | -0.81 % | $ 18.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 182.35 | -0.21 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
41.7 | $ 9.66 | -6.49 % | $ 1.25 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 269.81 | 0.66 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 392.8 | -0.63 % | $ 29.6 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 185.89 | -0.23 % | $ 15.3 B | ||
|
IDEXX Laboratories
IDXX
|
135 | $ 676.71 | -1.6 % | $ 55.8 B |